title: Follow-up study of patients diagnosed with chronic myelogenous leukemia treated with STI 571 in Ecuador.
authors.forename: César
authors.initials: C
authors.lastname: Paz-Y-Miño
authors.forename: Melissa
authors.initials: M
authors.lastname: Arévalo
authors.forename: María Eugenia
authors.initials: ME
authors.lastname: Sánchez
authors.forename: Claudio
authors.initials: C
authors.lastname: Cañizares
authors.forename: Paola E
authors.initials: PE
authors.lastname: Leone
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001549:Benzamides; D004484:Ecuador; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000175:diagnosis / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate